Label Image (Lbl530021707)
Spironolactone
Product Images NDC 53002-1707
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 53002-1707). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
20 (Spironolactone Tablets Usp 1)
10 (Spironolactone Tablets Usp 2)
This text appears to be reporting statistical information related to two drugs, Spironolactone and Piaceto. The sample size for Spironolactone is given as "n=822" and for Piaceto as "n=841". A statistical analysis was performed, and the result is shown as "Log-rank p: <0.001". It is unclear what the numbers at the end, "12 18 2% 30 3 4 48", refer to as they do not seem to be related to the statistical analysis.*
2 (Spironolactone Tablets Usp 3)
This appears to be a medical dataset with sections indicating various subgroups, age, sex, race, left ventricular ejection fraction (LVEF), diabetes status, serum creatinine levels, potassium levels, use of digoxin, angiotensin-converting enzyme inhibitor (ACEI), beta-blocker medications, heart rate, and a comparison of outcomes between spironolactone and placebo. However, the has produced many errors and unclear text, making it difficult to accurately interpret the specifics of the data.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
